Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 07, 2016 6:10 PM ET

Software

Company Overview of Paradigm Ltd.

Company Overview

Paradigm Ltd. develops software-enabled solutions for the global oil and gas industry. The company offers seismic processing and imaging, interpretation and modeling, reservoir characterization, reservoir engineering, and data management and interoperability solutions, as well as well planning, drilling engineering, and geo-steering solutions. Its solutions help natural resources companies in assisting their exploration and production decisions by providing deeper insight into the subsurface. The company also offers formation evaluation software for the assessment of well integrity to ensure safe operations; and well schematics and production logging tools to assist with post-production form...

Two Memorial Plaza

820 Gessner

Suite 400

Houston, TX 77024

United States

Founded in 1987

850 Employees

Phone:

713-393-4800

Fax:

713-393-4801

Key Executives for Paradigm Ltd.

Chief Executive Officer, President and Director
Age: 51
Founder and Non-Executive Chairman
Age: 58
Chief Financial Officer
Chief Operating Officer
Age: 58
Chief Technology Officer of Interpretation and Modeling
Age: 53
Compensation as of Fiscal Year 2015.

Paradigm Ltd. Key Developments

Paradigm Releases Paradigm Geolog 7.4

Paradigm announced that, it has released Paradigm Geolog 7.4, the latest version of its Geolog formation evaluation software suite. Geolog 7.4 offers a rich set of new engineering functionalities that expand the product's reach into additional phases of the production cycle. This release also extends third-party connectivity, including support for Petrel 2015, enabling users to bring the power of Geolog into workflows based in other products. Geolog 7.4 enhances the solution for engineers with tools to enable an independent assessment of well integrity, critical to ensuring safe operations; and new well schematics and production logging tools to assist with post-production formation evaluation. In addition, a new, full-functioned geomechanics module offers a comprehensive series of calculations and interactive tools for assessing mechanical conditions around the wellbore, resulting in a better understanding of the reservoir. New reservoir characterization plots enable the estimation of reservoir flow properties from log data. And the Geolog pore pressure prediction functionality is now available in a single integrated workflow, for improved efficiency.

Paradigm Announces Molecular Profiling Collaboration for Study of Altiratinib in Genomically Defined Cancer Patients

Paradigm announced a pharmaceutical services relationship with Deciphera Pharmaceuticals for a phase I clinical study of Altiratinib in molecularly defined cancers driven by either MET or TRK genomic alterations including lung cancer, gastric cancer, renal cancer, and glioblastoma multiforme (GBM). Paradigm will use its Paradigm Cancer Diagnostic (PCDx) panel's advanced molecular capabilities to characterize patient tissue samples from clinical trials to better predict which patients may be sensitive or resistant to Deciphera's Altiratinib, a MET/TIE2/VEGFR2/TRK (A,B,C) kinase inhibitor, which has been granted an Orphan Drug Designation for GBM by the FDA. PCDX is also broadly available to assist cancer patients and their oncologists find actionable FDA approved therapies.

Paradigm Expands Access to PCDx Medicine Service by Signing Contract with Three Rivers Provider Network

Paradigm has signed an agreement with Three Rivers Provider Network Inc. Under the terms of the agreement, Paradigm's Cancer Diagnostic Test (PCDx) will be available to more than 15 million US members of Three Rivers Provider Network. PCDx™ is a Next-Generation Sequencing (NGS) based diagnostic test that is designed to provide physicians and patients with information to allow a more targeted, approach to cancer treatment by identifying the underlying genomic and proteomic alterations of a patient's tumor's DNA, RNA & protein.

Similar Private Companies By Industry

Company Name Region
Edaptive Computing, Inc. United States
Funtank, LLC United States
Kamakura Corporation United States
RJG, Inc. United States
Interact Devices, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Paradigm Ltd., please visit www.pdgm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.